Significant Weight Loss: In higher-dose groups (12 mg), participants experienced average weight loss approaching 28% of body weight in long-term studies
This method focuses on improved tolerance, and sustainable outcomes while supporting healthy metabolic function
These medications work by helping regulate appetite, blood sugar, and feelings of fullness, which can lead to significant, sustained weight reduction for many patients
Additionally, we did not grade comorbid conditions at baseline, which might have caused some selection bias in the cohorts
Semaglutide belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists
M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F